CAD 3.95
(-2.47%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 384.2 Million | 368.7 Million | 261.4 Million | 198.8 Million | 204.3 Million | 346.2 Million |
Net Income | 83.1 Million | 132.6 Million | -3.7 Million | -150.4 Million | 14.5 Million | 121.7 Million |
Depreciation & Amortization | 228.8 Million | 201.2 Million | 187.8 Million | 181.4 Million | 168.6 Million | 189.3 Million |
Deferred income taxes | 35.3 Million | 34 Million | -29.4 Million | 15.6 Million | -3.2 Million | 33.9 Million |
Stock-based compensation | 14.2 Million | 7.2 Million | 7.9 Million | 7.8 Million | 5.7 Million | 6.9 Million |
Change in working capital | -22.7 Million | -19.9 Million | -73.7 Million | 57.8 Million | -3.8 Million | -4.2 Million |
Other non-cash items | 45.5 Million | 13.6 Million | 172.5 Million | 86.6 Million | 22.5 Million | -1.4 Million |
Investing Cash Flow | -341.8 Million | -280.8 Million | -315.8 Million | -225.8 Million | -239.7 Million | -229 Million |
Investments in PPE | -349.9 Million | -281.7 Million | -324.7 Million | -253.7 Million | -242.4 Million | -223.9 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | -6.4 Million |
Sales/Maturities of investments | - | - | 1.1 Million | 23.5 Million | - | - |
Other Investing Activities | 8.1 Million | 900 Thousand | 7.8 Million | 4.4 Million | 2.7 Million | 1.3 Million |
Financing Cash Flow | -57.8 Million | -130.2 Million | 25.1 Million | 159.5 Million | -21 Million | -79.3 Million |
Debt repayment | -43.5 Million | -130.2 Million | -27.1 Million | -22.7 Million | -15.4 Million | -63.9 Million |
Dividends payments | -14.3 Million | - | - | - | -6.3 Million | -18.6 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | 122.5 Million | 700 Thousand | 3.2 Million |
Other Financing Activities | - | -130.19 Million | 52.2 Million | 59.7 Million | 700 Thousand | 3.2 Million |
Accounts receivables | -26.3 Million | -19.9 Million | -14.7 Million | -22 Million | 1.8 Million | 9.2 Million |
Accounts payables | 26.3 Million | 19.9 Million | 13 Million | -6.4 Million | 9.3 Million | 3.4 Million |
Inventory | -16.3 Million | -15.9 Million | 4.4 Million | 6.4 Million | -16.5 Million | -16.1 Million |
Other working capital | 19.9 Million | 15.9 Million | -76.4 Million | 79.8 Million | 1.6 Million | 8.5 Million |
Cash at beginning of period | 83.2 Million | 133 Million | 179 Million | 49 Million | 107.7 Million | 73.2 Million |
Cash at end of period | 61.7 Million | 83.2 Million | 133 Million | 179 Million | 49 Million | 107.7 Million |
Capital Expenditure | -349.9 Million | -281.7 Million | -324.7 Million | -253.7 Million | -242.4 Million | -223.9 Million |
Effect of forex changes on cash | -6.1 Million | -7.5 Million | -16.7 Million | -2.5 Million | -2.3 Million | -3.4 Million |
Net cash flow / Change in cash | -21.5 Million | -49.8 Million | -46 Million | 130 Million | -58.7 Million | 34.5 Million |
Free Cash Flow | 34.3 Million | 87 Million | -63.3 Million | -54.9 Million | -38.1 Million | 122.3 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 34 Million | -5.3 Million | -18.9 Million | 83.1 Million | -5.5 Million | 68.6 Million |
Depreciation & Amortization | 69.9 Million | 64.8 Million | 71.8 Million | 228.8 Million | 51.7 Million | 60.2 Million |
Deferred income taxes | 2 Million | 7 Million | -2.7 Million | 35.3 Million | 8.6 Million | 18.9 Million |
Stock-based compensation | 3.5 Million | 4.9 Million | 2.8 Million | 14.2 Million | 2.3 Million | 3.6 Million |
Change in working capital | 8.5 Million | -2.5 Million | 5.3 Million | -22.7 Million | 2.6 Million | 6.3 Million |
Other non-cash items | 2.3 Million | 100 Thousand | 36.5 Million | 45.5 Million | 2.8 Million | 4.1 Million |
Investing Cash Flow | -76.6 Million | -73.5 Million | -78.7 Million | -341.8 Million | -92.1 Million | -89.4 Million |
Investments in PPE | -106.9 Million | -73.5 Million | -81.4 Million | -349.9 Million | -92.4 Million | -94.5 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 30.3 Million | - | 2.7 Million | 8.1 Million | 300 Thousand | 5.1 Million |
Financing Cash Flow | 47.7 Million | 19.2 Million | -13.9 Million | -57.8 Million | -22.7 Million | -14.6 Million |
Debt repayment | -45.8 Million | -19.2 Million | -6.8 Million | -43.5 Million | -22.7 Million | -7.4 Million |
Dividends payments | -7 Million | - | -7.1 Million | -14.3 Million | - | -7.2 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 100.5 Million | - | - | - | -22.7 Million | -7.4 Million |
Accounts receivables | 33.2 Million | -3.1 Million | -17.9 Million | -26.3 Million | -5.3 Million | 7.4 Million |
Accounts payables | - | - | 17.9 Million | 26.3 Million | 5.3 Million | -7.4 Million |
Inventory | 8.2 Million | 19 Million | -1.3 Million | -16.3 Million | -11.7 Million | 800 Thousand |
Other working capital | -23.4 Million | -6.4 Million | 24.5 Million | 19.9 Million | 14.3 Million | 5.5 Million |
Cash at beginning of period | 81.1 Million | 61.7 Million | 60.3 Million | 83.2 Million | 114.6 Million | 58 Million |
Cash at end of period | 157.3 Million | 81.1 Million | 61.7 Million | 61.7 Million | 60.3 Million | 114.6 Million |
Capital Expenditure | -106.9 Million | -73.5 Million | -81.4 Million | -349.9 Million | -92.4 Million | -94.5 Million |
Effect of forex changes on cash | -2.7 Million | -1.6 Million | -800 Thousand | -6.1 Million | -2 Million | -1.1 Million |
Net cash flow / Change in cash | 76.2 Million | 19.4 Million | 1.4 Million | -21.5 Million | -54.3 Million | 56.6 Million |
Free Cash Flow | 900 Thousand | 1.8 Million | 13.4 Million | 34.3 Million | -29.9 Million | 67.2 Million |
ACRE
BIO
KREF
BAZA3
LCTX
ALSE